๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Patient With Dyslipidemia

A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia NCT07230730Phase 31 site๐Ÿ“ Hangzhou Beijing Suncadia Pharmaceuticals Co., Ltd ยท Tests: SHR-1918, SHR-1918 placebo Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study) NCT07359105NA2 sites๐Ÿ“ Seoul๐Ÿ“ Seoul Sin Gon Kim ยท Tests: Moderate-intensity statin monotherapy, Ezetimibe or ezetimibe-statin combination therapy High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium NCT05845424Phase 41 site๐Ÿ“ Seoul Samsung Medical Center ยท Tests: Guideline directed statin therapy, High intensity statin plus ezetimibe therapy Evaluation of a New Virtual Care Pathway for Older Adults With Noncommunicable Diseases NCT07843238NA1 site๐Ÿ“ Kuala Lumpur National University of Malaysia ยท Tests: Teleconsultation care pathway for older adults with NCDs (TeleCOOP-NCDยฉ) A Study to Evaluate the Efficacy and Safety of AD-218 NCT05400317Phase 31 site๐Ÿ“ Daegu Addpharma Inc. ยท Tests: AD-218, AD-218A Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT NCT07720232Phase 41 site๐Ÿ“ Xiamen Jianyin Zhou ยท Tests: Live Combined Bacillus subtilis and Enterococcus faecium Enteric-coated Capsules (LCBE), Standard Care (in control arm) Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study NCT07523971n/a1 site๐Ÿ“ Daejeon JW Pharmaceutical A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol NCT07199309Phase 21 site๐Ÿ“ Chula Vista Marea Therapeutics ยท Tests: MAR001, Placebo Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia NCT06743659NA1 site๐Ÿ“ Boston Brigham and Women's Hospital ยท Tests: Alert-based computerized decision support A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe NCT07083206n/a1 site๐Ÿ“ Yongin-si Ahn-Gook Pharmaceuticals Co.,Ltd A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naรฏve Patients. NCT07619131Phase 3152 sites๐Ÿ“ Dothan๐Ÿ“ Chandler๐Ÿ“ Phoenix AstraZeneca ยท Tests: Laroprovstat, Rosuvastatin 1, Rosuvastatin 2, Laroprovstat/Rosuvastatin 1, Placebo to match rosuvastatin Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia NCT05365438Phase 41 site๐Ÿ“ Seongnam-si Seoul National University Bundang Hospital ยท Tests: Omega 3-Atorvastatin, Omega 3-Atorvastatin, Atorvastatin-Ezetimibe Effect of Two Food Supplements on Lipid Profile in Patients With Mild Hypercholesterolemia NCT07295327NA1 site๐Ÿ“ Pavia Fondazione IRCCS Policlinico San Matteo di Pavia ยท Tests: Cynacol, Metacol Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days NCT07614958Phase 31 site๐Ÿ“ Stockton-on-Tees A. Menarini International Licensing S.A. ยท Tests: Obicetrapib 10 mg/Bempedoic Acid Placebo, Bempedoic Acid 180mg/Placebo Obicetrapib A Post-Marketing Clinical Trial of Pemafibrate in Patients ๏ฝ—ith Hypercholesterolemia and Inadequate Response to Statins NCT07634484Phase 410 sites๐Ÿ“ Hokkaido๐Ÿ“ Ibaraki๐Ÿ“ Kagawa Kowa Company, Ltd. ยท Tests: Pemafibrate 0.2 mg/day, Pemafibrate 0.4 mg/day, Placebo A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia NCT07619118Phase 345 sites๐Ÿ“ Sun City West๐Ÿ“ Gardena๐Ÿ“ Lomita AstraZeneca ยท Tests: laroprovstat/rosuvastatin 1, laroprovstat/rosuvastatin 2, laroprovstat/rosuvastatin 3, laroprovstat/rosuvastatin 4, Plaโ€ฆ Group Medical Visits for Patients With Dyslipidemia NCT07543718NA1 site๐Ÿ“ Dieppe Universitรฉ de Sherbrooke ยท Tests: Group medical visits A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia NCT07206472n/a38 sites๐Ÿ“ Belo Horizonte๐Ÿ“ Belo Horizonte๐Ÿ“ Belo Horizonte Daiichi Sankyo ยท Tests: Combination of bempedoic acid and ezetimibe Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy NCT06300450NA1 site๐Ÿ“ Boston Brigham and Women's Hospital ยท Tests: Computer Alert Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention NCT06186037Phase 41 site๐Ÿ“ Suwon Saint Vincent's Hospital, Korea ยท Tests: Combination drug group of Ezetimibe 10 mg/Rosuvastatin 5 mg, Mono drug group of Rosuvastatin 20 mg LATAM LOWERS LDL-C NCT06501443Phase 411 sites๐Ÿ“ Corrientes๐Ÿ“ Salvador๐Ÿ“ Belo Horizonte Novartis Pharmaceuticals ยท Tests: Usual care, KJX839 CPAP Effect on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep Apnea NCT06463561Phase 41 site๐Ÿ“ Coslada Hospital Universitario La Paz ยท Tests: Continuous positive airway pressure, Hygienic-dietary recommendations and daily physical activity promotion Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia NCT07034690Phase 41 site๐Ÿ“ Abu Dhabi Novartis Pharmaceuticals ยท Tests: Educational Material, Standard of care Assessment of Compliance With European and French Guidelines for the Management of Dyslipidaemias NCT03449784n/a1 site๐Ÿ“ Montpellier University Hospital, Montpellier ยท Tests: Detection of patients with dyslipidemia Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia NCT06647888n/a1 site๐Ÿ“ Seoul Daewoong Pharmaceutical Co. LTD. ยท Tests: Envlo Tablet, Envlomet SR Tablet Effect of Ezetimibe on Gut Microbiota NCT06784557Phase 41 site๐Ÿ“ Seoul Yonsei University ยท Tests: Atorvastatin 40mg, Atorvastatin 20mg+Ezetimibe 10mg Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes NCT07102628Phase 369 sites๐Ÿ“ Capital Federal๐Ÿ“ Garran๐Ÿ“ Clayton Novartis Pharmaceuticals ยท Tests: Placebo, Inclisiran Pemafibrate for Symptomatic ICAS RCT NCT07562178NA37 sites๐Ÿ“ Toyoake๐Ÿ“ Yachiyo๐Ÿ“ Fukuyama Tokyo Women's Medical University ยท Tests: Pemafibrate Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels NCT06496243Phase 21 site๐Ÿ“ Philadelphia NewAmsterdam Pharma ยท Tests: obicetrapib 10 mg + obicetrapib/evolocumab 140 mg Q 2 weeks Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol NCT07028749Phase 255 sites๐Ÿ“ Anniston๐Ÿ“ Mobile๐Ÿ“ Little Rock Marea Therapeutics ยท Tests: MAR001, Placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy